These results appeared qualitatively similar to the human LS/HNPCC CAPP2 ASA chemoprevention trials [30] and supported the conclusion that the VpC-Msh2 mouse was an effective model for LS/HNPCC tumorigenesis and ASA tumor suppression. Here, MSH2 is linked to hereditary nonpolyposis colon cancer.